Brannan, S. K., Mallinckrodt, C. H., Brown, E. B. et al.: Duloxetine 60 mg once-daily in the treatment of painful physical symptoms in patients with major depressive disorder. J. Psychiatr. Res., 39: 43-53, 2005.
Burke, W. J., Gergel, I., Bose, A.: Fixed-dose trial of the single isomer SSRI escitalopram in depressed outpatients. J. Clin. Psychiatry, 63: 331-336, 2002.
Bymaster, F. P., Dreshfield-Ahmad, L. J., Threlkeld, P. G. et al.: Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors. Neuropsychopharmacology, 25: 871-880, 2001.
Bymaster, F. P., Lee, T. C., Knadler, M. P. et al.: The dual transporter inhibitor duloxetine: a review of its preclinical pharmacology, pharmacokinetic profile, and clinical results in depression. Curr. Pharm. Des., 11: 1475-1493, 2005.